Compare · MKD vs MPLN
MKD vs MPLN
Side-by-side comparison of Molecular Data Inc. (MKD) and MultiPlan Corporation (MPLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MKD and MPLN operate in Business Services (Consumer Discretionary), so they compete in similar markets.
- MPLN is the larger of the two at $2.41B, about 38.8x MKD ($62.0M).
- MPLN has more recent analyst coverage (7 ratings vs 0 for MKD).
- Company
- Molecular Data Inc.
- MultiPlan Corporation
- Price
- $0.42-13.65%
- $23.17-1.43%
- Market cap
- $62.0M
- $2.41B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 7
Molecular Data Inc.
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. Molecular Data Inc. was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
MultiPlan Corporation
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim. It also provides health benefit plans, which features reference-based pricing and tools to engage health plan members and providers to make the use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third party administrators, insurance bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, and auto medical markets. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Latest MKD
- SEC Form SC 13G filed by Molecular Data Inc.
- SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)
- SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)
- SEC Form SC 13G filed by Molecular Data Inc.
- SEC Form 25-NSE filed by Molecular Data Inc.
- 12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
- Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
- Why Cepton Is Trading Higher By 19%; Here Are 28 Stocks Moving Premarket
- SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)
- 12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
Latest MPLN
- ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks
- SEC Form 10-K filed by MultiPlan Corporation
- MultiPlan Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025
- MultiPlan Corporation filed SEC Form 8-K: Other Events
- Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design
- MultiPlan Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- MultiPlan Enters New Era and Unveils New Brand, Claritev, Reflecting Company's Transformation and Mission to Support the Healthcare Continuum
- Amendment: SEC Form SCHEDULE 13G/A filed by MultiPlan Corporation
- MultiPlan Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits